Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LY9 antibody (AA 156-253)

The Mouse Polyclonal anti-LY9 antibody has been validated for WB and ELISA. It is suitable to detect LY9 in samples from Human.
Catalog No. ABIN561701

Quick Overview for LY9 antibody (AA 156-253) (ABIN561701)

Target

See all LY9 (CD229) Antibodies
LY9 (CD229) (Lymphocyte Antigen 9 (CD229))

Reactivity

  • 46
  • 8
  • 4
  • 1
Human

Host

  • 32
  • 17
  • 1
Mouse

Clonality

  • 32
  • 18
Polyclonal

Conjugate

  • 25
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This LY9 antibody is un-conjugated

Application

  • 25
  • 17
  • 14
  • 14
  • 13
  • 13
  • 11
  • 11
  • 5
  • 5
  • 4
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB), ELISA
  • Binding Specificity

    • 15
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 156-253

    Purpose

    Mouse polyclonal antibody raised against a partial recombinant LY9.

    Sequence

    EPQVTMKSVK VSENFSCNIT LMCSVKGAEK SVLYSWTPRE PHASESNGGS ILTVSRTPCD PDLPYICTAQ NPVSQRSSLP VHVGQFCTDP GASRGGTT

    Cross-Reactivity

    Human

    Characteristics

    Antibody Reactive Against Recombinant Protein.

    Immunogen

    LY9 (NP_002339, 156 a.a. ~ 253 a.a) partial recombinant protein with GST tag.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    50 % glycerol

    Handling Advice

    Aliquot to avoid repeated freezing and thawing.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Target

    LY9 (CD229) (Lymphocyte Antigen 9 (CD229))

    Alternative Name

    LY9

    Background

    Full Gene Name: lymphocyte antigen 9
    Synonyms: CD229,SLAMF3,hly9,mLY9

    Gene ID

    4063

    NCBI Accession

    NM_002348

    Pathways

    BCR Signaling
You are here:
Chat with us!